iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate

Go back to iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate
IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.42 +0.02 (1.43%)
Previous Close $1.40    52 Week High $0.80 
Open $1.38    52 Week Low $0.34 
Day High $1.43    P/E N/A 
Day Low $1.34    EPS $-0.08 
Volume 349,974